Document is current

Article History

Received: 25 March 2023

Revised: 22 June 2023

Accepted: 23 July 2023

First Online: 24 August 2023

Change Date: 14 September 2023

Change Type: Update

Change Details: One of the supplementary files is missing which resulted to incorrect linking of the supplementary files. This has been added and the supplementary file captions have been corrected.

Declarations

:

: Independent Ethics Committee (IEC) or Institutional Review Board (IRB). The clinical study protocol, protocol amendments, materials used to recruit subjects, informed consent forms (ICFs) and materials to document consent, and any other appropriate study-related documents were reviewed and approved by IECs and Competent Ethics Committees (CECs) before initiations of the study at each study center.

: This study was conducted in accordance with the accepted version of the Declaration of Helsinki, United States Food and Drug Administration (FDA) Law, the European Union (EU) Clinical Trials Directive 2001/20/EC, in compliance with International Council for Harmonization (ICH) good clinical practice (GCP) E6 R2 guidelines, and according to the appropriate regulatory requirements in the countries where the study was conducted.

: Informed consent was obtained from all individual participants included in the study.

: IS reports financial support from Aerie Pharmaceuticals Ireland Ltd during the conduct of this study; and grants and personal fees from Théa and Santen, personal fees from Eye-D Pharma, Allergan-Abbvie, Horus and Alcon, and is a co-founder and shareholder of, and consultant for, MONA, outside the submitted work.KSL reports grants and lecture fees from Santen during the conduct of the study.FO reports grants and personal fees from Santen and Abbvie outside the submitted work.MF reports personal fees and non-financial support from Santen outside the submitted work.JIB reports personal fees from Glaukos, Zeiss and Santen, and personal fees and non-financial support from Esteve, outside the submitted work.AH reports personal fees from Aerie Pharmaceuticals Ireland Ltd during the conduct of this study, and personal fees from Théa and Santen outside the submitted work.GL has nothing to disclose.CS reports personal fees from Abbvie, Horus, Glaukos, Théa, Alcon, Santen, Nicox and Johnson & Johnson outside the submitted work.BV reports grants from Aerie Pharmaceuticals Ireland Ltd during the conduct of this study and grants from Santen outside the submitted work.TZ has nothing to disclose.GH reports personal fees from Santen outside the submitted work.